Arif Dalvi Selected Research

Nucleotides

5/2006

Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arif Dalvi Research Topics

Disease

4	Dyskinesias (Dyskinesia) 01/2023 - 03/2006
4	Parkinson Disease (Parkinson's Disease) 01/2023 - 03/2006
1	Ageusia (Hypogeusia) 01/2023
1	Dysarthria (Spastic Dysarthria) 01/2023
1	Dystonic Disorders (Writer's Cramp) 09/2008
1	Torticollis (Wryneck) 09/2008
1	Dystonia (Limb Dystonia) 01/2005
1	Movement Disorders (Movement Disorder) 01/2005
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2004
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2004

Drug/Important Bio-Agent (IBA)

2	Botulinum Toxins (Botulinum Toxin)IBA 09/2008 - 01/2005
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 03/2006 - 03/2006
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	Levodopa (L Dopa)FDA LinkGeneric 05/2006
1	NucleotidesIBA 05/2006
1	Dopamine Receptors (Dopamine Receptor)IBA 05/2006
1	Opioid Receptors (Opioid Receptor)IBA 05/2006
1	mu Opioid Receptors (mu Opioid Receptor)IBA 05/2006
1	Dopamine (Intropin)FDA LinkGeneric 05/2006
1	fluorodopa F 18IBA 03/2006
1	OligonucleotidesIBA 12/2004

Therapy/Procedure

2	Pallidotomy 01/2023 - 05/2009
1	Injections 09/2008
1	Deep Brain Stimulation 09/2008
1	Therapeutics 05/2006